Cover Stories

Early-Stage PROTAC Development and the Road to IND

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Cover Article October 2025 By Shanghao Li, Ph.D. Researchers first proposed the concept of targeted protein degradation more than 20 years ago (1). Today, the first drug candidate of proteolysis-targeting chimeras (PROTACs) is finally close to reaching ...

ICH Q1 Revision Introduces a New Era of Stability Testing

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Scientific Feature August 2025 Kim Huynh-Ba, MS, PMP, FAAPS Managing Director, Pharmalytik LLC, Newark DE Abstract The 2025 revision of the ICH Q1 guideline represents a significant advancement in global stability testing expectations. By consolidating ...

Advancing Vision: The Role of Printing Technologies in Therapeutic Ocular Contact Lens Innovation

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Cover Article August 2025 Sai HS. Boddu1,2, Abeer M. Al-Ghananeem1,2, and Vibhuti Agrahari 3 1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE 2Center of Medical and Bio-Allied Health Sciences ...

Nitrosamine Control Strategies: From Risk Identification to Implementation

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Cover Article July 2025 Jason Brown*, Adare Pharma Solutions and Kim Huynh-Ba, Pharmalytik, LLC *Corresponding Author  Abstract Nitrosamine impurities have emerged as a significant concern across the pharmaceutical industry, prompting global regulatory ...

Bugs as Drug Carriers

Posted By Matt Baughman
Found In Microsite: AAPS Newsmagazine
Cover Article June 2025 By Kafilat Agbaje, MSPS, Oluwabukunmi Olajubutu, MSPS, Omotola Gbadegesin, Ph.D. Modern medicine is in constant pursuit of smarter, safer, and more targeted ways to deliver drugs. While pills, patches, and nanoparticles ...